Matthew Ronsheim – Biography
Last update: April 17, 2026Executive profile
Matthew was President at Innoviva Specialty Therapeutics, and President at Entasis Therapeutics. Matthew Ronsheim joined Xenon in 2024.
Matthew Ronsheim is currentlyChief Operating Officer at Xenon - View - Xenon org chart
Create your alert
to follow the career of Matthew Ronsheim.
Education
Matthew Ronsheim has a Bachelor of Science in Chemistry from Southern Connecticut State University and a PhD in Synthetic Organic Chemistry from University of New Hampshire.
They have also studied at Southern Connecticut State University :
Find more alumni from Southern Connecticut State University
They have also studied at University of New Hampshire :
Find more alumni from University of New Hampshire
More about Matthew Ronsheim
Selected links
Do you need to know more about Matthew Ronsheim? More results.
Participate
Social media
- Matthew Ronsheim on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Matthew Ronsheim
The colleagues of Matthew Ronsheim
Company Colleagues
- At Xenon, Matthew Ronsheim has 24 colleagues including Ian Mortimer (CEO & Director), Justin Gover (Director)…
Industry Colleagues
- In the Pharmaceuticals industry, Matthew Ronsheim has 22,988 colleagues in 1,914 companies located in 68 countries. 10,852 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Matthew Ronsheim.
Get in Touch
Here are a few tips for establishing great contacts.
